跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,762 条关于
“Ustekinumab-srlf”
全部
5,762
临床试验
5,400
药物
58
机构
94
资讯
210
去年
FDA Approves Accord BioPharma's IMULDOSA (Ustekinumab-srlf) as Biosimilar
去年
FDA Approves Accord BioPharma's IMULDOSA, a Biosimilar to Stelara, for Inflammatory Conditions
去年
Imuldosa (Ustekinumab-srlf) Receives FDA Approval as Stelara Biosimilar
去年
Ustekinumab Biosimilars Approved, Data Support Biosimilar Safety, and Adalimumab Biosimilar Offers Cost Savings
前天
Canada Approves Multiple Denosumab and Ustekinumab Biosimilars as Global Competition Intensifies
5个月前
Accord BioPharma's Ustekinumab Biosimilar IMULDOSA Gains Preferred Status on Cigna Healthcare Formularies
去年
Accord BioPharma Launches IMULDOSA Biosimilar at 92% Discount to STELARA
去年
FDA Approves New Treatments for Severe Pain, UTIs, RSV, Hemophilia B, and Autoimmune Diseases
去年
Advancements in Crohn's Disease Treatment: Emerging Therapies and Market Trends
10个月前
FDA Approves Accord BioPharma's Denosumab Biosimilars OSVYRTI and JUBEREQ for Bone Disorders
第 1 页,共 21 页
上一页
下一页